[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO854655L - Fremgangsmaate ved fremstilling av flavolignanderivateer. - Google Patents

Fremgangsmaate ved fremstilling av flavolignanderivateer.

Info

Publication number
NO854655L
NO854655L NO854655A NO854655A NO854655L NO 854655 L NO854655 L NO 854655L NO 854655 A NO854655 A NO 854655A NO 854655 A NO854655 A NO 854655A NO 854655 L NO854655 L NO 854655L
Authority
NO
Norway
Prior art keywords
flavol
signature
derivatives
procedure
preparation
Prior art date
Application number
NO854655A
Other languages
English (en)
Other versions
NO160205C (no
NO160205B (no
Inventor
Reinhard Braatz
Klaus Goerler
Guenter Halbach
Hartwig Soicke
Karlheinz Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of NO854655L publication Critical patent/NO854655L/no
Publication of NO160205B publication Critical patent/NO160205B/no
Publication of NO160205C publication Critical patent/NO160205C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
NO854655A 1984-11-22 1985-11-21 Fremgangsmaate ved fremstilling av silibininderivater. NO160205C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (3)

Publication Number Publication Date
NO854655L true NO854655L (no) 1986-05-23
NO160205B NO160205B (no) 1988-12-12
NO160205C NO160205C (no) 1989-03-22

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
NO854655A NO160205C (no) 1984-11-22 1985-11-21 Fremgangsmaate ved fremstilling av silibininderivater.

Country Status (29)

Country Link
JP (1) JPS61143377A (no)
KR (1) KR870001020B1 (no)
AR (1) AR240931A1 (no)
AT (1) AT393268B (no)
BE (1) BE903693A (no)
CA (1) CA1337124C (no)
CH (1) CH659473A5 (no)
CS (1) CS273610B2 (no)
DD (1) DD259191A1 (no)
DE (1) DE3442639A1 (no)
DK (1) DK164865C (no)
EG (1) EG19424A (no)
ES (1) ES8609311A1 (no)
FI (1) FI84064C (no)
FR (1) FR2573427B1 (no)
GB (1) GB2167414B (no)
HU (1) HU195503B (no)
IE (1) IE58791B1 (no)
IT (1) IT1190426B (no)
LU (1) LU86163A1 (no)
MX (1) MX168415B (no)
NL (1) NL192387C (no)
NO (1) NO160205C (no)
PL (1) PL146890B1 (no)
PT (1) PT81532B (no)
SE (1) SE465676B (no)
SU (1) SU1436875A3 (no)
YU (1) YU43689B (no)
ZA (1) ZA858951B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
WO2006094357A1 (en) * 2005-03-11 2006-09-14 Howard Florey Institute Of Experimental Physiology And Medicine Flavonoid compounds and uses thereof
AU2008323156B2 (en) * 2007-11-15 2012-05-31 Madaus Gmbh Silibinin component for the treatment of hepatitis
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
PT2430017T (pt) * 2009-05-14 2016-10-12 Madaus Gmbh Método para a preparação de silibinina amorfa
WO2014008341A2 (en) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and magnesium
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
SU1436875A3 (ru) 1988-11-07
GB2167414B (en) 1989-01-11
BE903693A (fr) 1986-05-22
FI84064C (fi) 1991-10-10
CH659473A5 (de) 1987-01-30
IT8522932A0 (it) 1985-11-21
ATA337185A (de) 1991-02-15
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
DD259191A1 (de) 1988-08-17
AR240931A2 (es) 1991-03-27
MX168415B (es) 1993-05-24
DK164865C (da) 1993-01-18
PT81532B (pt) 1987-11-11
HUT40114A (en) 1986-11-28
FR2573427A1 (fr) 1986-05-23
FR2573427B1 (fr) 1989-03-10
SE8505487L (sv) 1986-05-23
YU43689B (en) 1989-10-31
NL192387C (nl) 1997-07-04
ZA858951B (en) 1986-08-27
LU86163A1 (de) 1986-03-24
DK537785D0 (da) 1985-11-21
AR240931A1 (es) 1991-03-27
DK164865B (da) 1992-08-31
HU195503B (en) 1988-05-30
AT393268B (de) 1991-09-25
SE8505487D0 (sv) 1985-11-20
DE3442639A1 (de) 1986-05-22
PT81532A (de) 1985-12-01
ES549116A0 (es) 1986-09-01
NO160205C (no) 1989-03-22
NL192387B (nl) 1997-03-03
FI854535A (fi) 1986-05-23
JPH0432073B2 (no) 1992-05-28
NO160205B (no) 1988-12-12
CS837885A2 (en) 1990-08-14
KR870001020B1 (ko) 1987-05-23
CS273610B2 (en) 1991-03-12
JPS61143377A (ja) 1986-07-01
FI84064B (fi) 1991-06-28
FI854535A0 (fi) 1985-11-18
ES8609311A1 (es) 1986-09-01
GB8528226D0 (en) 1985-12-18
KR860004056A (ko) 1986-06-16
DK537785A (da) 1986-05-23
EG19424A (en) 1995-02-28
DE3442639C2 (no) 1989-08-10
GB2167414A (en) 1986-05-29
IE852808L (en) 1986-05-22
IE58791B1 (en) 1993-11-17
YU178685A (en) 1988-02-29
IT1190426B (it) 1988-02-16
PL256374A1 (en) 1986-12-02
NL8503171A (nl) 1986-06-16
CA1337124C (en) 1995-09-26

Similar Documents

Publication Publication Date Title
NO852124L (no) Fremgangsmaate ved fremstilling av kinolonderivater.
NO885106D0 (no) FremgangsmŸte ved fremstilling av cytidin-derivater.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO852994L (no) Fremgangsmaate ved fremstilling av glutaramidderivater.
NO170071C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO880068D0 (no) Fremgangsmaate ved fremstilling av heteroaryl-3-okso-propannitrilderivater.
NO166032C (no) Fremgangsmaate ved fremstilling av triklormonosilan.
NO160206C (no) Fremgangsmaate ved fremstilling av isosilybinfri silibinin.
NO855356L (no) Fremgangsmaate ved fremstilling av cefem-derivater.
NO884665D0 (no) Fremgangsmaate ved fremstilling av 9-oh-alkoksyguanin.
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO861474L (no) Fremgangsmaate ved fremstilling av fenetanolaminderivater.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO854655L (no) Fremgangsmaate ved fremstilling av flavolignanderivateer.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO851758L (no) Fremgangsmaate ved fremstilling av isokinolinderivater
NO862233D0 (no) Fremgangsmaate ved fremstilling av imidazoquinazolinderivater.
NO851638L (no) Fremgangsmaate ved fremstilling av iminothiazolidin-derivater
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO166710C (no) Fremgangsmaate ved fremstilling av uretaner.
NO165538C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO881055D0 (no) Fremgangsmaate ved fremstilling av okso-isoindolinyl-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2002